Epithalon and Immune Longevity: Research on Immunosenescence

Immunosenescence: The Aging Immune System

Immune aging, or immunosenescence, involves progressive deterioration of both innate and adaptive immunity. Key features include:

• Thymic involution: Progressive loss of thymic tissue and naive T-cell output from early adulthood
• T-cell exhaustion: Accumulation of senescent T cells with reduced functional capacity
• Inflammaging: Chronic low-grade inflammation driven by senescent cells and innate immune dysregulation
• Reduced NK cell function: Declining cytotoxicity despite maintained NK cell numbers
• B-cell dysfunction: Reduced antibody diversity and affinity maturation

Epithalon Research in Immune Aging

Thymic Function

Khavinson's group demonstrated that epithalon treatment in aging rodents and primates:

• Preserved thymic cortical/medullary architecture
• Maintained thymosin production
• Increased circulating naive CD4+ T cells
• Reduced terminally differentiated effector T cells (TEMRA)

NK Cell Activity

In vitro studies showed epithalon enhanced NK cell cytotoxicity against K562 target cells by approximately 40% compared to untreated controls from aged donors. This effect was not observed in young donor cells (suggesting restoration rather than supraphysiologic enhancement).

Tumor Surveillance

Longevity studies with epithalon showed reduced spontaneous tumor incidence in aging rodents:

• Reduced mammary adenocarcinoma incidence in predisposed strains
• Lower leukemia rates in high-risk rodent lines
• Extended tumor-free survival period

Researchers attribute this partly to maintained immune surveillance capacity.

Inflammatory Markers

Epithalon treatment in aged animals reduced:

• Serum IL-6 levels
• TNF-alpha production
• CRP equivalents in rodent models
• NF-κB activity in tissue samples

Longevity Trial Summary (Rodent Data)

Study

Model

Mean Lifespan Increase

Khavinson 2003	Aging mice	+12.3%
Anisimov 2006	Cancer-prone mice	+8.5%
Khavinson 2014	Aged rats	+11.0%

Research Perspective

Epithalon's multi-system effects on immune aging — spanning thymus, NK cells, T-cell subsets, and inflammatory tone — make it a valuable research tool for studying integrated aging biology. Its well-characterized safety profile across multiple animal studies supports continued investigation.

Research-grade epithalon 50mg from Apollo Peptide Sciences — for laboratory research only.